FDA Transparency Push Expands to Monitoring Safety of Vaccines and Other Regulated Products / MedCity

Frank Vinluan / medcitynews - The FDA said consolidating safety reporting into a single platform, the Adverse Event Monitoring System (AEMS), will increase transparency and reduce costs. But like the legacy systems it replaces, AEMS reports are unverified so causation and frequency of…

#healthcare #pharmaceuticals #publichealth #governmentpolicy #biotech #fda #vaccinesafety #digitalhealth #animalhealth

---

Thursday, March 12, 2026, 5:23 pm / permalink 20659 / 7 stories in 4 days

Related Stories

---

• FDA launches individualized therapy framework for ultra-rare diseases / 20 days
• FDA makes one pivotal trial the default for drug approvals / 25 days
• FDA to review Moderna’s experimental flu vaccine after reversal / 26 days
• FDA refuses to review Moderna mRNA flu vaccine application / 4 wks
• FDA rejects Atara cell therapy for Epstein–Barr virus complications / 2 months
• FDA commissioners warn against sweeping vaccine policy changes / 3 months
• FDA clears first Alzheimer’s blood test as capillary sampling research advances biomarker access / 4 wks

Related Tags

---

StackHealth Time Machine

---